Pfizer Cambridge Site Head Discusses New State-of-the-Art R&D Facility

Description:

José-Carlos Gutiérrez-Ramos, Ph.D., discusses how the opening of Pfizer's new R&D hub in Cambridge provides unique benefits to fuel innovation, collaboration and a steady flow of new therapies for patients.

Download: